Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Biden Cheers Vaccine Progress but Says Masks Remain a Must
President-elect Joe Biden is cheering news about the promising development of a coronavirus vaccine, but cautioned Americans need to be aggressive about mask wearing and social distancing as infections continue to surge around the country.
Trump Threatens to Fire Fauci in Rift With Disease Expert
Speaking early Monday at a campaign rally in Opa-locka, Florida, Trump expressed frustration that the surging cases of a virus that has killed more than 231,000 people in the United States remains in the news, sparking chants of “Fire Fauci” from his supporters.
Load More